Skip to main content

Iron Triangle Partners LP

13F filer · CIK 0001779763
Last filed Feb 17, 2026
Inactive · not filing 13F
13F portfolio value$875MU.S. long equity reported on 13F
Positions2716 new · 14 closed
Net flow last quarter+$88.7MBuys minus sells
Top 10 positions weight53.2%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q4 2025Reported Feb 17, 202627 positions
CRLCharles River Laboratories International, Inc.$75.7M8.66%0.77%+41.7%Q1 2020
ISRGIntuitive Surgical Inc$53.5M6.12%0.03%Not reportedQ4 2019
RGENRepligen Corp$52.5M6.00%0.57%+18.7%Q4 2019
JAZZJazz Pharmaceuticals plc$49.7M5.68%0.48%+94.8%Q1 2025
VCYTVeracyte, Inc.$41.3M4.72%1.24%+102.1%Q3 2025
BSXBoston Scientific Corp$40.1M4.59%0.03%Not reportedQ4 2019
WATWaters Corp$39.9M4.57%0.18%Not reportedQ2 2021
BKDBrookdale Senior Living Inc.$37.7M4.31%1.47%+23.0%Q1 2020
LLYELI LILLY & Co$37.7M4.31%0.00%-29.3%Q3 2025
BRKRBruker Corp$37.4M4.28%0.52%Not reportedQ3 2023
VRTXVertex Pharmaceuticals Inc / Ma$34.9M3.99%0.03%NewQ4 2025
CVSCVS HEALTH Corp$34.3M3.92%0.03%-45.8%Q2 2025
FTREFortrea Holdings Inc.$34.3M3.92%2.13%Not reportedQ1 2024
MMSIMerit Medical Systems Inc$34M3.89%0.65%Not reportedQ3 2024
BTSGBrightSpring Health Services, Inc.$33.6M3.84%0.47%-27.5%Q1 2025
DOCSDoximity, Inc.$30.4M3.48%0.37%+226.9%Q4 2024
TECHBIO-TECHNE Corp$27.5M3.14%0.30%Not reportedQ1 2025
ATECAlphatec Holdings, Inc.$27.1M3.09%0.86%NewQ4 2025
AHCOAdaptHealth Corp.$26M2.97%1.93%+35.6%Q4 2021
NVSTEnvista Holdings Corp$25.8M2.95%0.72%Not reportedQ4 2019
UNHUnitedhealth Group Inc$23.1M2.65%0.01%Not reportedQ4 2020
ABTAbbott Laboratories$22M2.51%0.01%NewQ4 2025
IDYAIDEAYA Biosciences, Inc.$16.2M1.85%0.53%+73.1%Q3 2025
BHVNBiohaven Ltd.$10.8M1.24%0.72%NewQ4 2025
XENEXenon Pharmaceuticals Inc.$10.5M1.20%0.29%NewQ4 2025
DNTHDianthus Therapeutics, Inc.$9.51M1.09%0.53%NewQ4 2025
MLYSMineralys Therapeutics, Inc.$9.33M1.07%0.32%NewQ4 2025
Q3 2025Reported Nov 14, 202525 positions
CVSCVS HEALTH Corp$60.2M8.55%0.06%+6.4%Q2 2025
DXCMDexcom Inc$57.2M8.13%0.22%Not reportedQ4 2019
ABBVAbbVie Inc.$46.4M6.60%0.01%-19.9%Q1 2021
MDTMedtronic plc$43.2M6.14%0.04%+13.3%Q2 2025
CRLCharles River Laboratories International, Inc.$41.9M5.96%0.54%-16.3%Q1 2020
LLYELI LILLY & Co$37.8M5.38%0.01%NewQ3 2025
BTSGBrightSpring Health Services, Inc.$36.6M5.21%0.69%+3.2%Q1 2025
RGENRepligen Corp$36.1M5.13%0.48%Not reportedQ4 2019
GKOSGLAUKOS Corp$28M3.98%0.60%+26.4%Q2 2023
THCTenet Healthcare Corp$27.9M3.97%0.16%-27.7%Q2 2021
EXKEndeavour Silver Corp$27.4M3.89%0.19%+66.7%Q4 2019
ADPTAdaptive Biotechnologies Corp$27.2M3.87%1.19%+21.7%Q4 2019
MDGLMadrigal Pharmaceuticals, Inc.$26.8M3.81%0.26%NewQ3 2025
GHGuardant Health, Inc.$25M3.55%0.32%+33.3%Q4 2019
BKDBrookdale Senior Living Inc.$24M3.42%1.20%+67.0%Q1 2020
CAHCardinal Health Inc$21.7M3.08%0.06%+31.1%Q4 2024
JAZZJazz Pharmaceuticals plc$19.8M2.81%0.25%Not reportedQ1 2025
NBIXNeurocrine Biosciences Inc$18.4M2.62%0.13%Not reportedQ2 2022
WSTWest Pharmaceutical Services Inc$18.4M2.61%0.10%Not reportedQ1 2024
AHCOAdaptHealth Corp.$17.2M2.45%1.42%+0.2%Q4 2021
VCYTVeracyte, Inc.$16.7M2.37%0.61%NewQ3 2025
FOLDAmicus Therapeutics, Inc.$15.5M2.21%0.64%NewQ3 2025
DOCSDoximity, Inc.$15.4M2.18%0.11%-55.4%Q4 2024
IDYAIDEAYA Biosciences, Inc.$7.35M1.04%0.31%NewQ3 2025
ARGXArgenx SE$7.3M1.04%0.02%-36.4%Q1 2024
Q2 2025Reported Aug 14, 202526 positions
CVSCVS HEALTH Corp$51.7M7.94%0.06%NewQ2 2025
CRLCharles River Laboratories International, Inc.$48.6M7.46%0.65%Not reportedQ1 2020
ABBVAbbVie Inc.$46.4M7.13%0.01%+29.7%Q1 2021
MMSIMerit Medical Systems Inc$36.7M5.64%0.66%+71.0%Q3 2024
ICLRIcon PLC$36.4M5.58%0.32%Not reportedQ2 2021
MDTMedtronic plc$34.9M5.35%0.03%NewQ2 2025
THCTenet Healthcare Corp$33.4M5.14%0.20%-9.3%Q2 2021
ISRGIntuitive Surgical Inc$32.6M5.01%0.02%+100.0%Q4 2019
HCAHCA Healthcare, Inc.$30.6M4.71%0.03%Not reportedQ4 2019
DOCSDoximity, Inc.$28.9M4.44%0.25%+30.9%Q4 2024
BTSGBrightSpring Health Services, Inc.$28.3M4.35%0.68%+66.1%Q1 2025
GKOSGLAUKOS Corp$28M4.30%0.47%Not reportedQ2 2023
PODDInsulet Corp$21.4M3.28%0.10%-35.8%Q3 2022
AHCOAdaptHealth Corp.$18.1M2.78%1.42%+19.0%Q4 2021
CAHCardinal Health Inc$17.7M2.72%0.04%-64.9%Q4 2024
ADPTAdaptive Biotechnologies Corp$17.4M2.68%0.98%-29.9%Q4 2019
EXKEndeavour Silver Corp$15.9M2.45%0.11%Not reportedQ4 2019
TWSTTwist Bioscience Corp$15.6M2.40%0.71%+0.1%Q4 2019
GHGuardant Health, Inc.$15.6M2.40%0.24%-50.1%Q4 2019
ONCBeOne Medicines Ltd.$14.5M2.23%0.00%-38.7%Q1 2025
NVSTEnvista Holdings Corp$12.1M1.86%0.37%-49.7%Q4 2019
BKDBrookdale Senior Living Inc.$11.8M1.82%0.72%Not reportedQ1 2020
EHABEnhabit, Inc.$9.91M1.52%2.03%-9.8%Q1 2025
ALNYAlnylam Pharmaceuticals, Inc.$9.57M1.47%0.02%-55.2%Q3 2022
ARGXArgenx SE$8.58M1.32%0.03%-44.2%Q1 2024
INSMINSMED Inc$7.04M1.08%0.03%Not reportedQ2 2024
Q1 2025Reported May 15, 202527 positions
DVADavita Inc.$48.9M7.71%0.41%+22.7%Q3 2020
CAHCardinal Health Inc$41.3M6.52%0.12%+61.3%Q4 2024
ABBVAbbVie Inc.$40.4M6.37%0.01%-48.5%Q1 2021
TEVATeva Pharmaceutical Industries Ltd$34.1M5.37%0.19%+0.8%Q1 2020
BSXBoston Scientific Corp$33.5M5.28%0.02%-32.9%Q4 2019
GMEDGlobus Medical Inc$31.6M4.98%0.31%-48.9%Q4 2024
THCTenet Healthcare Corp$28.2M4.44%0.22%Not reportedQ2 2021
PODDInsulet Corp$27.8M4.39%0.15%-31.2%Q3 2022
AZNAstrazeneca PLC$27.7M4.36%Not reportedNot reportedQ3 2021
ONCBeOne Medicines Ltd.$26.6M4.20%0.01%NewQ1 2025
GHGuardant Health, Inc.$25.6M4.03%0.49%Not reportedQ4 2019
AAgilent Technologies, Inc.$24.4M3.84%0.07%-65.1%Q4 2024
MMSIMerit Medical Systems Inc$24.3M3.83%0.39%-43.6%Q3 2024
NVSTEnvista Holdings Corp$21.3M3.35%0.72%-44.0%Q4 2019
DOCSDoximity, Inc.$20.9M3.29%0.19%+15.2%Q4 2024
ALNYAlnylam Pharmaceuticals, Inc.$17.7M2.78%0.05%Not reportedQ3 2022
AHCOAdaptHealth Corp.$17.5M2.76%1.20%Not reportedQ4 2021
TWSTTwist Bioscience Corp$16.6M2.62%0.71%-13.9%Q4 2019
ARGXArgenx SE$16.5M2.60%0.05%-20.4%Q1 2024
NBIXNeurocrine Biosciences Inc$16.2M2.56%0.15%-53.9%Q2 2022
JAZZJazz Pharmaceuticals plc$16.1M2.54%0.21%NewQ1 2025
ADPTAdaptive Biotechnologies Corp$15.9M2.50%1.40%Not reportedQ4 2019
ISRGIntuitive Surgical Inc$14.9M2.34%0.01%-60.0%Q4 2019
TECHBIO-TECHNE Corp$14.7M2.31%0.16%NewQ1 2025
BTSGBrightSpring Health Services, Inc.$13.1M2.06%0.41%NewQ1 2025
EHABEnhabit, Inc.$10M1.58%2.26%NewQ1 2025
TXG10x Genomics, Inc.$8.73M1.38%0.82%Not reportedQ1 2023
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.